Therapeutic attempts of ghrelin and ghrelin receptor agonists used in cancer cachexia [152,162,163,164] and chemoprevention of inflammation-associated CRC carcinogenesis in animal models [157], have given rise to the idea of including such a therapy in humans. Here, GHSR is linked to colorectal carcinoma.